GlassScriptPhysician profile
Sergio Garcia
NPI 1649266297
$16,383.97
in general payments reported to CMS, 2019-2025
46 companies · $1,263 in 2025
The $1,263 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,580 · 2020: $1,044 · 2021: $1,095 · 2022: $1,811 · 2023: $1,591 · 2024: $8,000 · 2025: $1,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,600 · Food and Beverage: $4,287 · Travel and Lodging: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,599.95 |
| Food and Beverage | $4,287.31 |
| Travel and Lodging | $966.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,666.69 | 2024 | |
| Glaxosmithkline, LLC. | $2,265.44 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,499.95 | 2019-2024 | Fasenra, Breztri, Tezspire |
| Insmed, INC. | $1,054.72 | 2019-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $666.43 | 2019-2022 | |
| Baxter Healthcare | $435.07 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Genzyme Corporation | $402.78 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $312.43 | 2020-2023 | Ofev |
| Sunovion Pharmaceuticals INC. | $295.38 | 2019-2020 | |
| Inogen, INC. | $273.32 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Advanced Respiratory, INC | $244.71 | 2019-2021 | |
| Amgen INC. | $220.57 | 2021-2025 | Tezspire |
| Pulmonx Corporation | $219.51 | 2022-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Novartis Pharmaceuticals Corporation | $168.74 | 2019-2025 | |
| Genentech USA, INC. | $168.36 | 2019-2023 | Xolair |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.